Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
Original Article
S.P. Bhatt, K.F. Rabe, N.A. Hanania, C.F. Vogelmeier, J. Cole, M. Bafadhel, S.A. Christenson, A. Papi, D. Singh, E. Laws, L.P. Mannent, N. Patel, H.W. Staudinger, G.D. Yancopoulos, E.R. Mortensen, B. Akinlade, J. Maloney, X. Lu, D. Bauer, A. Bansal, L.B. Robinson, and R.M. Abdulai
N Engl J Med 2023;389:205-214
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation